Astrana Health, Inc. (NASDAQ:ASTH) Shares Sold by Rhumbline Advisers

Rhumbline Advisers cut its holdings in Astrana Health, Inc. (NASDAQ:ASTH) by 0.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 114,901 shares of the company’s stock after selling 1,049 shares during the quarter. Rhumbline Advisers owned about 0.20% of Astrana Health worth $3,623,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in ASTH. Nisa Investment Advisors LLC purchased a new stake in Astrana Health during the third quarter worth about $35,000. KBC Group NV purchased a new stake in Astrana Health during the third quarter worth about $70,000. Quarry LP purchased a new stake in Astrana Health during the third quarter worth about $77,000. Quest Partners LLC purchased a new stake in Astrana Health during the third quarter worth about $133,000. Finally, Paloma Partners Management Co purchased a new stake in Astrana Health during the third quarter worth about $220,000. 52.77% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages have issued reports on ASTH. Robert W. Baird upped their price target on shares of Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th. Truist Financial reduced their price target on shares of Astrana Health from $59.00 to $50.00 and set a “buy” rating on the stock in a report on Monday, January 13th. Macquarie raised shares of Astrana Health to a “hold” rating in a report on Monday, December 16th. Finally, Stifel Nicolaus reduced their price objective on shares of Astrana Health from $70.00 to $56.00 and set a “buy” rating on the stock in a research note on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $65.60.

Astrana Health Stock Performance

ASTH opened at $25.38 on Friday. The firm has a market cap of $1.43 billion, a PE ratio of 19.52, a P/E/G ratio of 1.37 and a beta of 1.20. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60. The business has a fifty day simple moving average of $35.01 and a 200-day simple moving average of $44.65. Astrana Health, Inc. has a fifty-two week low of $23.12 and a fifty-two week high of $63.20.

Astrana Health (NASDAQ:ASTH) last released its earnings results on Thursday, February 27th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.37). The business had revenue of $665.21 million during the quarter, compared to analysts’ expectations of $617.24 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. As a group, equities analysts predict that Astrana Health, Inc. will post 1.15 EPS for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.